Difference between revisions of "Stomach carcinoma"

Jump to navigation Jump to search
3,354 bytes added ,  20:53, 12 December 2019
(split out)
 
(20 intermediate revisions by 2 users not shown)
Line 1: Line 1:
'''Gastric carcinoma''', also '''carcinoma of the stomach''', is an epithelial derived [[malignant]] tumour that arises from the [[stomach]].
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Image      = Signet ring cell carcinoma - very high mag.jpg
| Width      =
| Caption    = Stomach signet ring cell carcinoma. [[H&E stain]].
| Synonyms  =
| Micro      =
| Subtypes  = Lauren classification: intestinal type, diffuse type; WHO classification: papillary carcinoma, tubular carcinoma, mucinous carcinoma, signet-ring carcinoma, undifferentiated carcinoma, [[adenosquamous carcinoma]]
| LMDDx      = [[gastric xanthoma]], [[neuroendocrine tumour]], metastatic carcinoma (e.g.[[pancreatic ductal adenocarcinoma]], [[gastric dysplasia]]
| Stains    = CK7 +ve, CK20 -ve/+ve
| IHC        =
| EM        =
| Molecular  =
| IF        =
| Gross      =
| Grossing  =
| Site      = [[stomach]]
| Assdx      =
| Syndromes  = [[hereditary diffuse gastric cancer]], [[familial adenomatous polyposis]], [[Lynch syndrome]], [[Peutz-Jeghers syndrome]], [[Li-Fraumeni syndrome]], [[Gastric adenocarcinoma and proximal polyposis of the stomach]] (GAPPS)
| Clinicalhx =
| Signs      =
| Symptoms  =
| Prevalence = uncommon
| Bloodwork  =
| Rads      =
| Endoscopy  = +/-[[linitis plastica]] (diffuse carcinomas), +/-ulcer with heaped (raised) edges (intestinal carcinomas)
| Prognosis  = usually very poor
| Other      =
| ClinDDx    = benign ulcer, other gastric tumours
| Tx        = surgery if feasible
}}
'''Stomach carcinoma''', also '''carcinoma of the stomach''' and '''gastric carcinoma''', is an epithelial derived [[malignant]] tumour that arises from the [[stomach]].


Many gastric carcinomas form glands and can thus be called '''gastric adenocarcinoma''' or '''adenocarcinoma of the stomach'''.
Many gastric carcinomas form glands and can thus be called '''gastric adenocarcinoma''' or '''adenocarcinoma of the stomach'''.
Line 11: Line 42:
*Associated with helicobacter infections, i.e. [[Helicobacter gastritis]].
*Associated with helicobacter infections, i.e. [[Helicobacter gastritis]].
*[[Alcohol]] - heavy use.<ref name=pmid21993435>{{Cite journal  | last1 = Duell | first1 = EJ. | last2 = Travier | first2 = N. | last3 = Lujan-Barroso | first3 = L. | last4 = Clavel-Chapelon | first4 = F. | last5 = Boutron-Ruault | first5 = MC. | last6 = Morois | first6 = S. | last7 = Palli | first7 = D. | last8 = Krogh | first8 = V. | last9 = Panico | first9 = S. | title = Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. | journal = Am J Clin Nutr | volume = 94 | issue = 5 | pages = 1266-75 | month = Nov | year = 2011 | doi = 10.3945/ajcn.111.012351 | PMID = 21993435 }}</ref>
*[[Alcohol]] - heavy use.<ref name=pmid21993435>{{Cite journal  | last1 = Duell | first1 = EJ. | last2 = Travier | first2 = N. | last3 = Lujan-Barroso | first3 = L. | last4 = Clavel-Chapelon | first4 = F. | last5 = Boutron-Ruault | first5 = MC. | last6 = Morois | first6 = S. | last7 = Palli | first7 = D. | last8 = Krogh | first8 = V. | last9 = Panico | first9 = S. | title = Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. | journal = Am J Clin Nutr | volume = 94 | issue = 5 | pages = 1266-75 | month = Nov | year = 2011 | doi = 10.3945/ajcn.111.012351 | PMID = 21993435 }}</ref>
*Genetic syndromes - see [[hereditary gastric cancer]].
*Genetic syndromes:
**[[Hereditary diffuse gastric cancer]].
**[[Familial adenomatous polyposis]].
**[[Peutz-Jeghers syndrome]].
**[[Lynch syndrome]].
**[[Gastric adenocarcinoma and proximal polyposis of the stomach]].<ref name=pmid30584346>{{Cite journal  | last1 = Rudloff | first1 = U. | title = Gastric adenocarcinoma and proximal polyposis of the stomach: diagnosis and clinical perspectives. | journal = Clin Exp Gastroenterol | volume = 11 | issue =  | pages = 447-459 | month =  | year = 2018 | doi = 10.2147/CEG.S163227 | PMID = 30584346 }}</ref>


Note:
Note:
Line 41: Line 77:
*Ulceration with heaped (raised) edges.
*Ulceration with heaped (raised) edges.
**Appearance of the typical intestinal type tumour.  
**Appearance of the typical intestinal type tumour.  
*Diffuse wall thickening with loss of the rugae - called ''linitis plastica''.
*Diffuse wall thickening with loss of the rugae - called ''[[linitis plastica]]''.
**Typically due to diffuse carcinoma.  
**Typically due to diffuse carcinoma.  


Main DDx of ulcer:
Main DDx of [[gastric ulcer]]:
*[[Peptic ulcer disease]] - have a "punched-out" appearance: sharp edge, no granularity of surrounding mucosa.
*[[Peptic ulcer disease]] - have a "punched-out" appearance: sharp edge, no granularity of surrounding mucosa.


Line 67: Line 103:
*[[Gastric xanthoma]] - may mimic signet ring cell carcinoma.
*[[Gastric xanthoma]] - may mimic signet ring cell carcinoma.
*[[Neuroendocrine tumour]] - esp. for poorly differentiated; no gland formation.
*[[Neuroendocrine tumour]] - esp. for poorly differentiated; no gland formation.
*Metastatic carcinoma.
**[[Pancreatic ductal adenocarcinoma]].
*[[Gastric dysplasia]].


===Grading===
===Grading===
Line 84: Line 123:


==IHC==
==IHC==
*AE1/AE3.
*CK7 +ve.
*CK7 +ve.
*CK20 -ve, occasionally +ve.
*CK20 -ve, occasionally +ve.
*[[CDX2]] +ve.<ref name=pmid12604886>{{Cite journal  | last1 = Werling | first1 = RW. | last2 = Yaziji | first2 = H. | last3 = Bacchi | first3 = CE. | last4 = Gown | first4 = AM. | title = CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. | journal = Am J Surg Pathol | volume = 27 | issue = 3 | pages = 303-10 | month = Mar | year = 2003 | doi =  | PMID = 12604886 }}</ref>


Others:
Others:
Line 94: Line 135:
**Poor prognosis - like in breast cancer.
**Poor prognosis - like in breast cancer.
**Scoring system different than in breast cancer - complete membrane staining is not required.
**Scoring system different than in breast cancer - complete membrane staining is not required.
==Staging==
*Sixteen (or more) lymph nodes should be assessed (as per the 7th Ed. of the UICC/AJCC staging).<ref name=pmid24744586>{{Cite journal  | last1 = Deng | first1 = JY. | last2 = Liang | first2 = H. | title = Clinical significance of lymph node metastasis in gastric cancer. | journal = World J Gastroenterol | volume = 20 | issue = 14 | pages = 3967-75 | month = Apr | year = 2014 | doi = 10.3748/wjg.v20.i14.3967 | PMID = 24744586 }}</ref>
**The 5th Ed. of the UICC/AJCC staging manual stated 15 lymph nodes.<ref name=pmid24744586/>


==Sign out==
==Sign out==
===Biopsy===
===Biopsy===
====Intestinal type====
====Intestinal type====
<pre>
Stomach, Biopsy:
- INVASIVE ADENOCARCINOMA, INTESTINAL TYPE, moderately differentiated.
- Gastric mucosa with intestinal metaplasia.
Comment:
The tumour stains as follows:
POSITIVE: CK7, CDX2.
NEGATIVE: CD20.
HER2 testing has been ordered and will be reported as an addendum.
</pre>
<pre>
<pre>
STOMACH, BIOPSY:
STOMACH, BIOPSY:
- INVASIVE ADENOCARCINOMA, INTESTINAL TYPE, MODERATELY DIFFERENTIATED.
- INVASIVE ADENOCARCINOMA, INTESTINAL TYPE, MODERATELY DIFFERENTIATED.
- Gastric mucosa with moderate chronic active inflammation and extensive
- Gastric mucosa with moderate chronic active inflammation and extensive
  intestinal metaplasia.
  intestinal metaplasia.
- Benign small bowel mucosa with erosions.
- Benign small bowel mucosa with erosions.
</pre>
</pre>
Line 133: Line 191:
==See also==
==See also==
*[[Stomach]].
*[[Stomach]].
*[[Siewert classification]].


==References==
==References==
48,453

edits

Navigation menu